Levosalbutamol Inhalation Solution 0.63MG – LIVENTA Inhalation Solution

LIVENTA Inhalation Solution
Composition:- Levosalbutamol Sulphate ip 0.63mg

LIVENTA Inhalation Solution – The composition of levosalbutamol inhalation solution 0.63mg contains the pure (R)-enantiomer of salbutamol, which exhibits higher bronchodilator activity at lower doses with fewer side effects. The formulation in saline solution ensures ease of nebulization, ideal for acute asthma, COPD, and pediatric respiratory distress.

Key Points of Levosalbutamol Inhalation Solution 0.63MG – LIVENTA Inhalation Solution

• Selective Beta-2 Agonist for Quick Bronchodilation: Provides rapid relief from bronchospasm by selectively stimulating beta-2 receptors in bronchial smooth muscles.
• Lower Side Effect Profile: Offers better tolerance with reduced cardiac stimulation compared to racemic salbutamol, making it suitable for sensitive individuals and pediatric use.
• Nebulized Delivery for Deep Lung Penetration: Ensures effective drug deposition directly into the lower respiratory tract for fast and sustained action.

Can be Prescribed by:

• Pulmonologists
• General Physicians
• Allergists
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion.